Cannabis for pain management among women of reproductive age in Pennsylvania.

<h3>Context</h3> Persistent pain is a frequent, complex health concern, often refractory to treatment. Despite limited research evidence, many patients perceive cannabis as a worthwhile alternative treatment for pain. <h3>Objective</h3> To assess the use and perceived usefulness of medical cannabis for pain care. <h3>Study Design</h3> An anonymous online survey was emailed to potential participants. Data was collected from August through October 2023. Descriptive statistics summarized the data. Setting Medical cannabis dispensary in south-central Pennsylvania. Population Females of reproductive age (18-55 years old) who were the cannabis dispensary clients. <h3>Instrument</h3> Survey questions asked the respondents about demographics, and cannabis use, indications, and experiences, especially in relation to pain. <h3>Outcome Measures N/A</h3> Results Among 847 survey respondents, the majority identified as white (88.3%) and non-Hispanic/Latino (86.7). They were, on average, 38.8 ± standard deviation (SD) 8.9 years old, started using cannabis at the age of 18.6±7.5 (range: 5-51) years, and were authorized to use medical cannabis for 3.4±3.4 years, with most (90.8%) authorized to use it for multiple indications; 392 (46.3%) reported pain as one of the indications. The majority of participants (n= 392, 46.3%) who used medical cannabis for pain self-care stated it helped their pain (94.9%). Over the past 30 days, the majority (71.9%) reported daily cannabis use, mainly through vaporization (80%) and smoking (72%), followed by swallowing (42%), oral absorption (38%) or topically (38%). Most of females using cannabis for pain care reported no side effects (261/392; 66.6%); the most common adverse effects, were worse memory (68/392, 17.3%) and anxiety (51/392, 13.0%). <h3>Conclusion</h3> Pain is a common reason for medical cannabis authorization among females of reproductive age. Medical cannabis, used in real world settings, is reported by the vast majority of users to help with pain, without serious adverse effects. More research is needed to better understand the effects and role of medical cannabis for pain care.

Authors

Publication Details

Journal
Pain Management
Published
2024-11-20
DOI
https://doi.org/10.1370/afm.22.s1.6987
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cannabis for pain management among women of reproductive age in Pennsylvania.

Wesley M. Raup‐Konsavage, Aleksandra E Zgierska, Kent E. Vrana, Arjola Agolli et al.
Pain Management
Cannabis and Cannabinoid Research
article

Cannabis for pain management among women of reproductive age in Pennsylvania.

Wesley M. Raup‐Konsavage, Aleksandra E Zgierska, Kent E. Vrana, Arjola Agolli, Samantha Murphy, Kylie Manuppelli
article en

Abstract

<h3>Context</h3> Persistent pain is a frequent, complex health concern, often refractory to treatment. Despite limited research evidence, many patients perceive cannabis as a worthwhile alternative treatment for pain. <h3>Objective</h3> To assess the use and perceived usefulness of medical cannabis for pain care. <h3>Study Design</h3> An anonymous online survey was emailed to potential participants. Data was collected from August through October 2023. Descriptive statistics summarized the data. Setting Medical cannabis dispensary in south-central Pennsylvania. Population Females of reproductive age (18-55 years old) who were the cannabis dispensary clients. <h3>Instrument</h3> Survey questions asked the respondents about demographics, and cannabis use, indications, and experiences, especially in relation to pain. <h3>Outcome Measures N/A</h3> Results Among 847 survey respondents, the majority identified as white (88.3%) and non-Hispanic/Latino (86.7). They were, on average, 38.8 ± standard deviation (SD) 8.9 years old, started using cannabis at the age of 18.6±7.5 (range: 5-51) years, and were authorized to use medical cannabis for 3.4±3.4 years, with most (90.8%) authorized to use it for multiple indications; 392 (46.3%) reported pain as one of the indications. The majority of participants (n= 392, 46.3%) who used medical cannabis for pain self-care stated it helped their pain (94.9%). Over the past 30 days, the majority (71.9%) reported daily cannabis use, mainly through vaporization (80%) and smoking (72%), followed by swallowing (42%), oral absorption (38%) or topically (38%). Most of females using cannabis for pain care reported no side effects (261/392; 66.6%); the most common adverse effects, were worse memory (68/392, 17.3%) and anxiety (51/392, 13.0%). <h3>Conclusion</h3> Pain is a common reason for medical cannabis authorization among females of reproductive age. Medical cannabis, used in real world settings, is reported by the vast majority of users to help with pain, without serious adverse effects. More research is needed to better understand the effects and role of medical cannabis for pain care.

Pain Management
Gender equality
Openalex Percentile: Top 79%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.